Teofiline, a new look to an old drug;Teofilina, una nueva mirada a un medicamento antiguo

Revista Alergia Mexico

Volumn 57, Issue 4, 2010, Pages 112-122

  Morfín Maciel, Blanca María ^a   Castillo Morfín, Blanca María ^b  

^a Hospital Angeles Mocel   (Mexico)

^b UNIVERSIDAD ANÁHUAC   (Mexico)

Author keywords

Antiinflammatory; Asthma; COPD; Corticoresistance; Histone deacetylase; Theophylline

Indexed keywords

ADENOSINE; CORTICOSTEROID; HISTONE DEACETYLASE 2; OXYGEN RADICAL; PHOSPHODIESTERASE; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENTIATION; DRUG SAFETY; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; MEDLINE; NITRATIVE STRESS; OXIDATIVE STRESS; SMOOTH MUSCLE; THEOPHYLLINE BLOOD LEVEL; TREATMENT RESPONSE;

EID: 78650774955     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. th ed. Philadelphia: Mosby, 2003;p:823-833.
2. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337(2):1412-1418.
3. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2008. Disponible en: http://www.ginasthma.org.
4. Barnes PJ. Theophylline. New perspectives for an old drug. Am J Respir Crit Care Med2003;167:813-818.
5. a ed. Ciudad de México: MacGraw-Hill Interamericana, 1999;p:707-731.
6. Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 2003;73(5):468-474.
7. Hannan SE, May JJ, Pratt DS, Richtsmeier WJ, Bertino JS. The effect of whole virus influenza vaccination on theophylline pharmacokinetics. Am Rev Respir Dis 1988;137(4):903-906.
8. Hendeles L, Massanari M, Weinberger M. Update on the pharmacodynamics and pharmacokinetics of theophylline. Chest 1985;88:103S-111S.
9. Chorostowska-Wynimko J, Kus J, Skopiska-Rozewska E. Theophylline inhibits free oxygen radicals production by human monocytes via phosphodiesterase inhibition. J Physiol Pharmacol 2007;58(Suppl 5):95-103.
10. Ezeamuzie CI. Involvement of A(3) receptors in the potentiation by adenosine of theinhibitory effect of theophylline on human eosinophil degranulation: possible novel mechanism of the anti-inflammatory action of theophylline. Biochem Pharmacol 2001;61(12):1551-1559.
11. Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ. Molecular mechanismsof interleukin-10-mediated inhibition of NF-kappa B activity: a role for p50. Clin Exp Immunol 2004;135(1):64-73.
12. Halasz A, Cserhati E, Cseh K. Role of the TNF system in the pathomechanism of bronchial asthma. Orv Hetil 2002;143(11):553-557.
13. kB activation in human peripheral blood mononuclear cells. Int Arch Allergy Immunol 2002;128(2):130-135.
14. Yasui K, Hu B, Nakazawa T, Komiyama A. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 1997;100:1677-1684.
15. Ohta K, Yamashita N. Apoptosis of eosinophils and lymphocytes in allergic inflammation. J Allergy Clin Immunol 1999;104:14-21.
16. Chung IY, Nam-Kung EK, Lee NM, Chang HS, et al. The downregulation of Bcl-2 expression is necessary for theophylline-induced apoptosis of eosinophil. Cell Immunol 2000;203(2):95-102.
17. Tagami T, Park Y, Jameson JL. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. J Biol Chem 1999;274(32):22345-22353.
18. Ito K, Lim S, Caramori G, Cosio B, et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 2002;99(13):8921-8926.
19. Fischle W, Kiermer V, Dequiedt F, Verdin E. The emerging role of class II histone deacetylases. Biochem Cell Biol 2001;79(3):337-348.
20. Ito K, Lim S, Caramori G, Chung KF, et al. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001;15:1100-1102.
21. Lim S, Jatakanon A, Gordon D, Macdonald C, et al. Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice. Thorax 2000;55:837-841.
22. Ukena D, Harnest U, Sakalauskas R, Magyar P, et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Pneumologie 1998;52(7):377-384.
23. Peralta J. Mecanismos de respuesta inflamatoria del organismo: implicancia del óxido nítrico. Disponible en: http://www. antioxidantes.com.ar/FrArt172.htm.
24. Barnes JP. Reduced histone deacetylase in COPD. Chest 2006;129:151-155.
25. Carvin A, Lindgren S. The effect of selective phosphodiesterase inhibitors on mucociliary activity in the upper and lower airways in vitro. Auris Nasus Larynx 1998;25(3):269-276.
26. Takashi S, Okubo Y, Horie S. Contribution of CD54 to human eosinophil and neutrophil superoxide production. J Appl Physiol 2001;91(2):613-622.
27. Lim S, Tomita K, Caramori G, Jatakanon A, et al. Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med 2001;164(2):273-276. (Pubitemid 34001294)
28. Ide T, Nichols DG, Buck JR, Eleff SM, et al. Effect of aminophylline on high-energyphosphate metabolism and fatigue in the diaphragm. Anesthesiology 1995;83(3):557-567.
29. Ahnadi CE, Sabrinah Chapman E, Lépine M, Okrongly D, et al. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy. Thromb Haemost 2003;90(5):940-948.
30. Park H, Clark E, Conklin JL. Effects of phosphodiesterase inhibitors on oesophagealneuromuscular functions. Neurogastroenterol Motil 2003;15(6):625-633.
31. Trevitt J, Kawa K, Jalil A, Larsen C. Differential effects of adenosine antagonists in two models of parkinsonian tremor. Pharmacol Biochem Behav 2009;94(1):24-29.
32. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta 2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000;(4):CD002742.
33. Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child 1998;79:405-410.
34. Dahl R, Larsen BB, Venge P. Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms. Respir Med 2002;96:432-438.
35. Wilson AJ, Gibson PG, Coughlan J. Long acting betaagonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2000;(2):CD001281.
36. Yurdakul AS, Taci N, Eren A, Sipit T. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma. Respir Med 2003;97(12):1313-1319.
37. Shah L, Wilson AJ, Gibson PG, Coughlan J. Long acting beta-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2003;(3):CD001281.
38. Yurdakul AS, Calisir HC, Tunctan B, Ogretensoy M. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. RespirMed 2002;96(5):322-329.
39. Markham A, Faulds D. Theophylline: a review of its potential steroid sparing effects in asthma. Drugs 1998;56:1081-1089.
40. Ream RS, Loftis LL, Albers GM, Becker BA, et al. Efficacy of IV theophylline in children with severe status asthmaticus. Chest 2001;119(5):1480-1488.
41. Holimon TD, Chafin CC, Self TH. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta 2 agonists? Drugs 2001;61(3):391-418.
42. Zuwallack RL, Mahler DA, Reilly D, Church N, et al. Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest 2001;119:1661-1670.
43. Bellia V, Foresi A, Bianco S, Grassi V, et al. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH trial). Respir Med 2002;96(11):881-889.
44. Barr RG, Rowe BH, Camargo CA Jr. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials. BMJ 2003;327:643-646.
45. Schatz M. The efficacy and safety of asthma medications during pregnancy. Semin Perinatol 2001;25(3):145-152.
46. Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2010;20(1):273.
47. Luskin AT. Drug side effects and disease interactions in the elderly asthmatic. Syllabus. 1999 ACAAI Annual meeting.